Drug Shortage Report for ACT DILTIAZEM CD

Last updated on 2021-05-26 History
Report ID 82555
Drug Identification Number 02370638
Brand name ACT DILTIAZEM CD
Common or Proper name DILTIAZEM CD
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 180MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-04-01
Estimated end date Unknown
Actual end date 2021-05-25
Shortage status Resolved
Updated date 2021-05-26
Company comments ACT Item is discontinued, TEVA DIN is now available.
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-05-26 English Compare
v4 2021-05-25 French Compare
v3 2021-05-25 English Compare
v2 2019-04-26 French Compare
v1 2019-04-26 English Compare

Showing 1 to 5 of 5